Idorsia Competitors and Similar CompaniesClear all
Idorsia's competitors and similar companies include Roivant Sciences, CSL Vifor, Ipsen, Regeneron Pharmaceuticals, Biocon, Pfizer, Roche and Novartis.
 Idorsia Idorsia, a biopharmaceutical company, discovers, develops, and commercializes drugs for unmet medical needs. |  CSL Vifor CSL Vifor (also known as Vifor Pharma Management) is a diversified group active throughout the healthcare market, which develops, manufactures, and markets pharmaceutical products. |  Regeneron Pharmaceuticals Regeneron Pharmaceuticals is a biopharmaceutical company that develops, manufactures, and markets medicines. |  Pfizer Pfizer is a research-based biopharmaceutical company engaged in the discovery, development, manufacture, and distribution of healthcare products. |  Novartis Novartis is a company that researches, develops, manufactures, and markets healthcare products. | |||||
Founding Date | Founding Date 2017 | Founding Date 2014 | Founding Date 1927 | Founding Date 1929 | Founding Date 1988 | Founding Date 1978 | Founding Date 1849 | Founding Date 1896 | Founding Date 1996 |
Type | Type Public | Type Public | Type Subsidiary | Type Public | Type Public | Type Public | Type Public | Type Public | Type Public |
Tags | |||||||||
Locations | Locations Allschwil, CH HQ Shanghai, CN Lörrach, DE Chiyoda City, JP | Locations London, GB HQ Basel, CH Boston, US New York, US | Locations Glattbrugg, CH HQ Buenos Aires, AR Melbourne, AU Melbourne, AU Wien, AT Antwerpen, BE São Paulo, BR see more | Locations Boulogne-Billancourt, FR HQ Algiers, DZ South Yarra, AU Wien, AT Merelbeke, BE São Paulo, BR Mississauga, CA see more | Locations Tarrytown, US HQ Mississauga, CA Courbevoie, FR München, DE Bengaluru, IN Dublin, IE Limerick, IE see more | Locations Bengaluru, IN HQ Bengaluru, IN Nanakramguda, IN Dublin, IE Kuala Lumpur, MY Puchong, MY Delémont, CH see more | Locations New York, US HQ Buenos Aires, AR Villa Adelina, AR Footscray, AU Mulgrave, AU Sydney, AU Wien, AT see more | Locations Basel, CH HQ Tirana, AL Buenos Aires, AR Macquarie Park, AU Kundl, AT Unterlangkampfen, AT Wien, AT see more | |
Employees | Employees 8007% increase | Employees 908 | Employees 2,200 | Employees 5,358 | Employees 15,1068% increase | Employees 16,5612% increase | Employees 81,0008% decrease | Employees 103,249 | Employees 75,883 |
Valuation ($) | Valuation ($) N/A | Valuation ($) 8.8 b | Valuation ($) N/A | Valuation ($) 10.2 b | Valuation ($) 102.2 b | Valuation ($) N/A | Valuation ($) 163.9 b | Valuation ($) N/A | Valuation ($) N/A |
Financial | |||||||||
Revenue (est.) | Revenue (est.) CHF220.6m (FY, 2025) | Revenue (est.) $8.3m (FY, 2025) | Revenue (est.) CHF1.8b (FY, 2021) | Revenue (est.) €3.7b (FY, 2025) | Revenue (est.) $14.3b (FY, 2025) | Revenue (est.) ₹167.8b (FY, 2026) | Revenue (est.) $62.6b (FY, 2025) | Revenue (est.) CHF61.5b (FY, 2025) | Revenue (est.) $56.7b (FY, 2025) |
Cost of goods | Cost of goods CHF20.9m (FY, 2025) | Cost of goods N/A | Cost of goods CHF498.7m (FY, 2021) | Cost of goods €659.1m (FY, 2025) | Cost of goods N/A | Cost of goods ₹56.9b (FY, 2026) | Cost of goods $16.1b (FY, 2025) | Cost of goods CHF13.1b (FY, 2025) | Cost of goods $8.4b (FY, 2025) |
Gross profit | Gross profit CHF214.3m (FY, 2025) | Gross profit N/A | Gross profit CHF1.3b (FY, 2021) | Gross profit €3.3b (FY, 2025) | Gross profit N/A | Gross profit ₹115.8b (FY, 2026) | Gross profit $46.5b (FY, 2025) | Gross profit CHF50.5b (FY, 2025) | Gross profit $49.8b (FY, 2025) |
Net income | Net income (CHF111.7m) (FY, 2025) | Net income ($397.9m) (FY, 2025) | Net income CHF265.4m (FY, 2021) | Net income €445.1m (FY, 2025) | Net income $4.5b (FY, 2025) | Net income ₹3.7b (FY, 2026) | Net income $7.8b (FY, 2025) | Net income CHF13.8b (FY, 2025) | Net income $14b (FY, 2025) |
Operating ⚠ | |||||||||
Patients | Patients N/A | Patients N/A | Patients N/A | Patients N/A | Patients N/A | Patients N/A | Patients N/A | Patients 22.8 m (FY, 2023) | Patients 10 m (FY, 2022) |
Phase I Trials Products | Phase I Trials Products N/A | Phase I Trials Products 4 (Q2, 2021) | Phase I Trials Products N/A | Phase I Trials Products N/A | Phase I Trials Products N/A | Phase I Trials Products N/A | Phase I Trials Products 51 (FY, 2024) | Phase I Trials Products N/A | Phase I Trials Products N/A |
Phase II Trials Products | Phase II Trials Products N/A | Phase II Trials Products 5 (Q2, 2021) | Phase II Trials Products N/A | Phase II Trials Products N/A | Phase II Trials Products N/A | Phase II Trials Products N/A | Phase II Trials Products 27 (FY, 2024) | Phase II Trials Products N/A | Phase II Trials Products N/A |
Phase III Trials Products | Phase III Trials Products N/A | Phase III Trials Products 1 (Q2, 2021) | Phase III Trials Products N/A | Phase III Trials Products N/A | Phase III Trials Products N/A | Phase III Trials Products N/A | Phase III Trials Products 32 (FY, 2024) | Phase III Trials Products N/A | Phase III Trials Products 44 (FY, 2022) |
Registration Phase Products | Registration Phase Products N/A | Registration Phase Products 1 (Q2, 2021) | Registration Phase Products N/A | Registration Phase Products N/A | Registration Phase Products N/A | Registration Phase Products N/A | Registration Phase Products 5 (FY, 2024) | Registration Phase Products N/A | Registration Phase Products 8 (FY, 2022) |
Funding | |||||||||
Total funding raised | Total funding raised N/A | Total funding raised $ 1.9b | Total funding raised N/A | Total funding raised N/A | Total funding raised $ 53.9m | Total funding raised N/A | Total funding raised N/A | Total funding raised $ 7.8b | Total funding raised $ 6.5m |
For sources of this data, please see the company profile
View Company Profiles
Roivant Sciences
HQ
London, GB
Employees
908
Roivant Sciences is a company that develops and commercializes medicines.
View companyCSL Vifor
HQ
Glattbrugg, CH
CSL Vifor (also known as Vifor Pharma Management) is a diversified group active throughout the healthcare market, which develops, manufactures, and markets pharmaceutical products.
View companyRegeneron Pharmaceuticals
HQ
Tarrytown, US
Employees
15,106↑ 8% increase
Regeneron Pharmaceuticals is a biopharmaceutical company that develops, manufactures, and markets medicines.
View company